To date, the exact role of the PNPLA3 I148M polymorphism in NAFLD is unclear, although mechanisms by which variation in PNPLA3 may affect liver triglyceride content have been hypothesized. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.